1182.9000 -1.00 (-0.08%)
NSE May 02, 2025 15:31 PM
Volume: 1.3M
 

Axis Direct
The company is building a global pipeline of biosimilars, developments of NCE for Immuno-oncology, and building up a Neutraceuticals portfolio, vaccines, CDMO, and digital healthcare platforms. However, high inflation could decrease margins prompting us to reduce TP to Rs 4,500/share.
Dr. Reddy's Laborato.. has an average target of 1347.12 from 10 brokers.
More from Dr. Reddy's Laboratories Ltd.
Recommended